| Stage | SAH | % of rev | CVNA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $7.5B | 100.00% | $8.0B | 100.00% | CVNA ×1.07 |
| Gross profit | $599M | 7.95% | $1.5B | 18.92% | CVNA +11.0pp |
| Operating income | $123M | 1.64% | $714M | 8.88% | CVNA +7.2pp |
| Pre-tax income | $73M | 0.97% | $552M | 6.87% | CVNA +5.9pp |
| Net income | $47M | 0.62% | $483M | 6.01% | CVNA +5.4pp |
| Stage | SAH | CVNA | Gap · A − B |
|---|---|---|---|
| Revenue | $7.5B100.00% | $8.0B100.00% | CVNA ×1.07 |
| Gross profit | 7.95%$599M | 18.92%$1.5B | CVNA +11.0pp |
| Operating income | 1.64%$123M | 8.88%$714M | CVNA +7.2pp |
| Pre-tax income | 0.97%$73M | 6.87%$552M | CVNA +5.9pp |
| Net income |
| 0.62%$47M |
| 6.01%$483M |
| CVNA +5.4pp |
No shared counterparties.